Sexual dysfunction in the elderly: Age or disease?

International Journal of Impotence Research

Volumn 17, Issue SUPPL. S1, 2005, Pages

  Camacho, M E ^a   Reyes Ortiz, C A ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Aging; Elderly; Sexual dysfunction

Indexed keywords

AMFEBUTAMONE; ANTIHYPERTENSIVE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARVEDILOL; CLONIDINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOPAMINE RECEPTOR BLOCKING AGENT; FIBRIC ACID DERIVATIVE; METHYLDOPA; METOPROLOL; MIRTAZAPINE; NEFAZODONE; NEUROLEPTIC AGENT; NICOTINIC ACID; PRASTERONE; PROPRANOLOL; SILDENAFIL; TESTOSTERONE; TIMOLOL; TRICYCLIC ANTIDEPRESSANT AGENT;

AGING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DEPRESSION; DIABETES MELLITUS; DISEASE CONTROL; EMOTION; ENDOTHELIUM; ERECTILE DYSFUNCTION; FEMALE SEXUAL DYSFUNCTION; HUMAN; INTIMACY; LIFESTYLE; OBESITY; PHYSICIAN; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTION; SEXUAL FUNCTION; SEXUALITY; TESTOSTERONE BLOOD LEVEL; URINARY TRACT DISEASE;

AGED; AGED, 80 AND OVER; AGING; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; FEMALE; HUMANS; IMPOTENCE; MALE; MIDDLE AGED; PREVALENCE; PROSTATIC NEOPLASMS; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL; SEXUALITY;

EID: 30044431986     PISSN: 09559930     EISSN: 14765489     Source Type: Journal    
DOI: 10.1038/sj.ijir.3901429     Document Type: Review

References (67)

1. Mulligan T, Reddy S, Gulur PV, Godschalk M. Disorders of male sexual function. Clin Geriatr Med 2003; 19: 473-481.
2. Marandola P et al. Love and sexuality in aging. Aging Male 2002; 5: 103-113.
3. Gott M, Hinchliff S. How important is sex in later life. The views of older people. Soc Sci Med 2003; 56: 1617-1628.
4. Matthias RE et al. Sexual activity and satisfaction among very old adults: results from a community-dwelling Medicare population survey. Gerontologist 1997; 37: 6-14.
5. Jung A, Wolf-Berhard S. Male sexuality with advancing age. Eur J Obstet Gynecol Reprod Biol 2004; 113: 123-125.
6. Master WH, Johnson VE. Sex and the aging process. J Am Geriatr Soc 1981; 29: 385-390.
7. Nicolosi A et al. GSSAB Investigators' Group. Sexual behaviour and dysfunction and help-seeking patterns in adults aged 40-80 years in the urban population of Asian countries. BJU Int 2005; 95: 609-614.
8. Shiri R et al. Prevalence and severity of erectile dysfunction in 50 to 75 year old Finnish men. J Urol 2003; 170: 2342-2344.
9. Laumann EO et al. GSSAB Investigators' Group. Sexual problems among women and men aged 40-80 y: prevalence and correlates identified in the Global Study of Sexual Attitudes and Behaviors. Int J Impot Res 2005; 17: 39-57.
10. Rosen R et al. Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the ageing male (MSAM-7). Eur Urol 2003; 44: 637-639.
11. Eardley I et al. Efficacy and safety of tadalafil in a Western European population of men with erectile dysfunction. BJU Int 2004; 94: 871-877.
12. Prins J et al. Prevalence of erectile dysfunction: a systematic review of population based studies. Int J Impot Res 2002; 14: 422-432.
13. Feldman HA et al. Impotence and its medical and psychosocial correlates: result of the Massachusetts male aging study. J Urol 1994; 151: 54-61.
14. Eardley I et al. The sexual habits of British men and women over 40 years old. BJU Int 2004; 93: 563-567.
15. Rosen RC. Reproductive health problems in ageing men. Lancet 2005; 366: 183-185.
16. Nicolosi A et al. Sexual behavior and sexual dysfunctions after age 40: the global study of sexual attitudes and behaviors. Urology 2004; 64: 991-997.
17. Salonia A et al. Women's sexual dysfunction: a pathophysiological review. BJU Int 2004; 93: 1156-1164.
18. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States. Prevalence and predictors. JAMA 1999; 281: 537-544.
19. Billups KL et al. Erectile dysfunction is a marker of cardiovascular disease: results of the minority health institute expert advisory panel. J Sex Med 2005; 2: 40-52.
20. Morley JE, Tariq SH. Sexuality and disease. Clin Geriatr Med 2003; 19: 563-573.
21. Solomon H, Man J, Jackson G. Erectile dysfunction and the cardiovascular patient: endothelial dysfunction is the common denominator. Heart 2003; 89: 251-253.
22. Kaiser DR et al. Impaired brachial artery endothelium dependent and independent vasodilatation in men with erectile dysfunction and no other clinical cardiovascular disease. J Am Coll Cardiol 2004; 43: 179-184.
23. Billups KL et al. Relation of C-reactive protein and other cardiovascular risk factors to penile vascular disease in men with erectile dysfunction. Int J Impot Res 2003; 4: 231-236.
24. Fung MM, Bettencout R, Barret-Connor E. Heart disease risk factors predict erectile dysfunction 25 years later: the Rancho Bernardo study. J Am Coll Cardiol 2004; 43: 1405-1411.
25. Esposito K, Giugliano D. Obesity, the metabolic syndrome, and sexual dysfunction. Int J Impot Res 2005; 17: 391-398.
26. Tan RS, Pu SJ. Impact of obesity on hypogonadism in the andropause. Int J Androl 2002; 25: 195-201.
27. Esposito K et al. Effect of life style changes on erectile dysfunction in obese men. A randomized controlled trial. JAMA 2004; 291: 2978-2984.
28. Ponholzer A et al. Prevalence and risk factors for erectile dysfunction in 2869 men using a validated questionnaire. Eur Urol 2005; 47: 80-86.
29. Foresta C et al. Erectile dysfunction: symptom or disease? J Endocrinol Invest 2004; 27: 80-95.
30. Kloner RA. Assessment of cardiovascular risk in patients with erectile dysfunction: focus on the diabetic patient. Endocrine 2004; 23: 125-129.
31. Doruk H et al. Effect of diabetes mellitus on female sexual function and risk factors. Arch Androl 2005; 51: 1-6.
32. Nikoobakht M, Nasseh H, Pourkasmaee M. The relationship between lipid profile and erectile dysfunction. Int J Impot Res 2005; 17: 523-536.
33. Blumentals WA, Gomez-Caminero A, Joo S, Vannappagari V. Should erectile dysfunction be considered as a marker for acute myocardial infarction? Results from a retrospective cohort study. Int J Impot Res 2004; 16: 350-353.
34. Currey HLF. Osteoarthritis of hip joint and sexual activity. Ann Rheum Dis 1970; 29: 488-493.
35. Zeiss ERA, Delmonico RL, Zeiss AM, Dornbrand L. Psychological disorder and sexual dysfunction in elders. Clin Geriatr Med 1991; 1: 133-151.
36. Hansen BL. Lower urinary tract symptoms (LUTS) and sexual function in both sexes. Eur Urol 2004; 46: 229-234.
37. Gregorian RS et al. Antidepressant-induced sexual dysfunction. Ann Pharmacother 2002; 10: 1577-1589.
38. Montejo AL, Llorca G, Izquierdo JA, Villademoros F. Incidence of sexual dysfunction associated with antidepressants agents: a prospective multicenter study of 1022 outpatients. J Clin Psychiatry 2001; 62: 10-21.
39. Damis M, Patel Y, Simpson GM. Sildenafil in the treatment of SSRI-induced sexual dysfunction: a pilot study. Primary care companion. J Clin Psychiatry 1999; 6: 184-187.
40. Jensen J et al. The prevalence and etiology of impotence in 101 male hypertensive outpatients. Am J Hypertens 1999; 12: 271-275.
41. Franzen D et al. Effects of beta-blockers on sexual performance in men with coronary heart disease: a prospective, randomized and double blind study. Int J Impot Res 2001; 13: 348-351.
42. Steiner SS et al. Antihypertensive therapy and quality of life: a comparison of atenolol, captopril, enalapril and propranolol. J Hum Hypertens 1990; 4: 217-225.
43. Rizvi K, Hampson JP, Harvey JN. Do lipid lowering drugs cause erectile dysfunction? A systematic review. Fam Pract 2002; 19: 95-98.
44. Johannes CB et al. Incidence of erectile dysfunction in men 40-69 years old: longitudinal results from the Massachusetts male aging study. J Urol 2000; 163: 460-463.
45. Barret-Connor E. Cardiovascular risk stratification and cardiovascular risk factors associated with erectile dysfunction: assessing cardiovascular risk in men with erectile dysfunction. Clin Cardiol 2004; 4(Suppl 1): 18-113.
46. Wald M et al. Computational models for detection of erectile dysfunction. J Urol 2005; 173: 167-170.
47. Morley JE et al. Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men. Metabolism 1997; 46: 410-413.
48. Feldman HA et al. Age trends in the level of serum testosterone and other hormones in middle age men: longitudinal results from the Massachusetts male aging study. J Clin Endocrinol Metab 2002; 87: 589-598.
49. Mulligan T et al. Amplified nocturnal luteinizing-hormone (LH) secretory burst frequency with selective attenuation of pulsatile (but not basal) testosterone secretion in healthy aged men- possible Leydig-cell desensitation to endogenous LH signaling - a clinial research center study. J Clin Endocrinol Metab 1995; 80: 3025-3031.
50. Veldhuis JD, Swart A, Mulligan T, Iramanesh A. Muting of androgen negative feedback unveils impoverished gonadotropin-releasing hormone/luteinizing hormone secretory reactivity in healthy older men. J Clin Endocrinol Metab 2001; 86: 529-535.
51. MacFarlane GJ et al. The relationship between sexual life and urinary condition in the French community. J Clin Epidemiol 1996; 49: 1171-1176.
52. Blanker MH et al. Correlates of erectile and ejaculatory function in older Dutch men: a community-based study. J Am Geriatr Soc 2001; 49: 436-442.
53. Kirby RS, O'Learly MP, Carson C. efficacy of extended-release doxazosin and doxazosin standard in patients with concomitant benign prostatic hyperplasia and sexual dysfunction. BJU Int 2005; 95: 103-109.
54. Dahn J et al. Sexual functioning and quality of life after prostate cancer treatment: considering sexual desire. Urology 2004; 63: 273-277.
55. Derby CA et al. Measurement of erectile dysfunction in population-based studies: the use of a single question self-assessment in the Massachusetts male aging study. Int J Urol 2000; 12: 197-204.
56. Rosen RC. Evaluation of the patient with erectile dysfunction: history, questionnaires, and physical examination. Endocrine 2004; 23: 107-111.
57. Capelleri JC, Rosen RC. The sexual health inventory for men (SHIM): a 5-year review of research and clinical experience. Int J Impot Res 2005; 17: 307-319.
58. Torrance GW et al. Development and initial validation of a new preference-based disease-specific health-related quality of life instrument for erectile dysfunction. Qual Life Res 2004; 13: 349-359.
59. Heineman LA, Saad F, Heineman K, Thai DM. Can results of the aging males's symptoms (AMS) scale predict those of screening scales for androgen deficiency? Aging male 2004; 7: 211-218.
60. Moynihan R. The making of a disease: female sexual dysfunction. BMJ 2003; 326: 45-47.
61. Basson R et al. Report of the International Consensus Development Conference on Female Sexual Dysfunction: definitions and classifications. J Urol 2000; 163: 888-893.
62. Seagraves RT. Female sexual disorders: psychiatric aspects. Can J Psychiatry 2002; 5: 419-425.
63. Nusbaum MRH, Singh AR, Pyles AA. Sexual healthcare needs of women aged 65 and older. J Am Geriatr Soc 2004; 52: 117-122.
64. Cayan S, Bozlu M, Canpolat B, Akbay E. The assessment of sexual functions in women with male partners complaining of erectile dysfunction: does treatment of male sexual dysfunction improve female partner's sexual function? J Sex Marital Ther 2004; 30: 333-341.
65. Ichikawa T et al. The female partner's satisfaction with sildenafil citrate treatment of erectile dysfunction. Int J Urol 2004; 11: 755-762.
66. Clayton AH. Female sexual dysfunction related to depression and antidepressant medications. Curr Womens Health Rep 2002; 3: 182-187.
67. Turna B et al. Women with low libido: correlation of decreased androgen levels with female sexual function index. Int J Urol 2005; 2: 148-153.